Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor

Molecular Pharmacology

Volumn 52, Issue 3, 1997, Pages 508-514

  Robinson, Susan W ^a,b   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DOPAMINE 3 RECEPTOR; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROLEPTIC AGENT; QUINPIROLE; SPIPERONE;

AFFECT; ARTICLE; BINDING AFFINITY; EMOTION; ENZYME ACTIVITY; ENZYME BINDING; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; SCHIZOPHRENIA;

EID: 0030775397     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.3.508     Document Type: Article

References (32)

1. Jackson, D. M., and A. Westlind-Danielsson. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol. Ther. 64: 291-369 (1994).
2. Jaber, M., S. W. Robinson, C. Missale, and M. G. Caron. Dopamine receptors and brain function. Neuropharmacology 35:1503-1519 (1996).
3. 3) as a target for neuroleptics. Nature (Lond.) 347:146-151 (1990).
4. 2 dopamine receptors. Mol. Pharmacol. 45:51-60 (1994).
5. 3 dopamine receptor. J. Pharmacol. Exp. Ther. 268:417-426 (1994).
6. 3 dopamine receptors. J. Neurosci. 14:1463-1476 (1994).
7. 4 dopamine receptors in HEK293 cells. J. Recept. Signal Transduct. Res. 15:267-281 (1995).
8. 3 dopamine receptors in differentiated neuroblastoma X glioma NG108-15 cells. Br. J. Pharmacol. 111:391-393 (1994).
9. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89:8155-8159 (1992).
10. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268:495-502 (1994).
11. Ishikawa, Y., S. Katsushika, L. Chen, N. J. Halnon, J.-I. Kawabe, and C. J. Homcy. Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J. Biol. Chem. 267:13553-13557 (1992).
12. Premont, R. T., J. Chen, H.-W. Ma, M. Ponnapalli, and R. Iyengar. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc. Natl. Acad. Sci. USA 89:9809-9813 (1992).
13. Glatt, C. E., and S. H. Snyder. Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature (Lond.) 361:536-538 (1993).
14. s-stimulated adenylyl cyclases. FASEB J. 7:768-775 (1993).
15. Sunahara, R. K., C. W. Dessauer, and A. G. Gilman. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. 36:461-480 (1996).
16. Kawabe, J.-I., G. Iwami, T. Ebina, S. Ohno, T. Katada, Y. Ueda, C. J. Homey, and Y. Ishikawa. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269:16554-16558 (1994).
17. Iwami, G., J.-I. Kawabe, T. Ebina, P. J. Cannon, C. J. Homcy, and Y. Ishikawa. Regulation of adenylyl cyclase by protein kinase A. J. Biol. Chem. 270:12481-12484 (1995).
18. 2+-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions. Mol. Brain Res. 22:236-244 (1994).
19. Cullen, B. R. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152:684-704 (1987).
20. 3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells. J. Neurochem. 67: 212-219 (1996).
21. 3H]cAMP in cell monolayers, cell suspensions, and tissue slices. Methods Enzymol. 195:22-28 (1991).
22. Barr, A. J., L. F. Brass, and D. R. Manning. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells: a direct evaluation of selectivity in receptor-G protein coupling. J. Biol. Chem. 272: 2223-2229 (1997).
23. Tang, W.-J., and A. G. Gilman. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Washington D. C.) 254:1500-1503 (1991).
24. i-protein βγ subunits. Nature (Lond.) 356:159-161 (1992).
25. sα. Biochemistry 33:12852-12859 (1994).
26. Premont, R. T. Identification of adenylyl cyclases by amplification using degenerate primers. Methods Enzymol. 238:116-127 (1994).
27. Watson, P. A., J. Krupinski, A. M. Kempinski, and C. D. Frankenfield. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J. Biol. Chem. 269:28893-28898 (1994).
28. Hellevuo, K., M. Yoshimura, M. Kao, P. L. Hoffman, D. M. F. Cooper, and B. Tabakoff. A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem. Biophys. Res. Commun. 192:311-318 (1993).
29. Taussig, R., W.-J. Tang, J. R. Hepler, and A. G. Gilman. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J. Biol. Chem. 269:6093-6100 (1994).
30. iα. Science (Washington D. C.) 261:218-221 (1993).
31. Chen, Z, H. S. Nield, H. Sun, A. Barbier, and T. B. Patel. Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J. Biol. Chem. 270:27562-27568 (1995).
32. Sun, H., J. M. Seyer, and T. B. Patel. A region in the cytosolic domain of the epidermal growth factor receptor antithetically regulates the stimulatory and inhibitory guanine nucleotide-binding regulatory proteins of adenylyl cyclase. Proc. Natl. Acad. Sci. USA 92:2229-2233 (1995).